Glenmark Pharmaceuticals Inc.
GPTKB entity
Properties (62)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
nan
|
gptkbp:awards |
Various industry awards
|
gptkbp:CEO |
gptkb:Rakesh_K._Kachru
|
gptkbp:clinicalTrials |
Completed
Ongoing |
gptkbp:community_engagement |
Educational initiatives
Health awareness programs Support for local health initiatives |
gptkbp:employees |
Over 10,000
|
gptkbp:environmentalProtection |
Sustainable_practices
|
gptkbp:financialPerformance |
Publicly traded
|
gptkbp:founded |
1977
|
gptkbp:founder |
gptkb:Glenmark_Pharmaceuticals
|
gptkbp:headCoach |
Approximately 10,000
|
gptkbp:headquarters |
gptkb:Mumbai
|
https://www.w3.org/2000/01/rdf-schema#label |
Glenmark Pharmaceuticals Inc.
|
gptkbp:investmentFocus |
Research and development
Significant Market expansion Technology upgrades |
gptkbp:market |
gptkb:Asia
gptkb:Latin_America gptkb:North_America Africa Europe |
gptkbp:operates_in |
Global market
|
gptkbp:parent_company |
gptkb:Glenmark_Pharmaceuticals_Ltd.
|
gptkbp:partnerships |
Academic institutions
Research organizations Various global pharmaceutical companies Healthcare_providers |
gptkbp:patentCitation |
Numerous patents filed
|
gptkbp:products |
Branded drugs
Active pharmaceutical ingredients (APIs) Generic_drugs |
gptkbp:regulatoryCompliance |
gptkb:FDA
EMA TGA |
gptkbp:research_areas |
Gastroenterology
Pain management Diabetes Neurology Infectious diseases |
gptkbp:research_focus |
Oncology
Respiratory diseases Cardiovascular diseases Dermatology Chronic diseases |
gptkbp:sells |
gptkb:BSE
NSE |
gptkbp:social_responsibility |
CSR initiatives
|
gptkbp:stockExchange |
GLENMARK
|
gptkbp:subsidiary |
gptkb:Glenmark_Generics_Ltd.
Glenmark_Specialty_S.A. |
gptkbp:sustainability_initiatives |
Energy efficiency programs
Water conservation efforts Waste management initiatives Reduce carbon footprint Community health improvement |
gptkbp:type |
Public company
|
gptkbp:website |
www.glenmarkpharma.com
|